Sandra Ictech

591 total citations
12 papers, 469 citations indexed

About

Sandra Ictech is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Sandra Ictech has authored 12 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Genetics, 7 papers in Pulmonary and Respiratory Medicine and 4 papers in Molecular Biology. Recurrent topics in Sandra Ictech's work include Glioma Diagnosis and Treatment (10 papers), Brain Metastases and Treatment (5 papers) and Cancer Research and Treatments (3 papers). Sandra Ictech is often cited by papers focused on Glioma Diagnosis and Treatment (10 papers), Brain Metastases and Treatment (5 papers) and Cancer Research and Treatments (3 papers). Sandra Ictech collaborates with scholars based in United States. Sandra Ictech's co-authors include Victor A. Levin, Kenneth R. Hess, W.K. Alfred Yung, Mary Jo Gleason, Morris D. Groves, Howard Colman, Mark R. Gilbert, Vinay K. Puduvalli, Michael D. Prados and Charles A. Conrad and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Sandra Ictech

12 papers receiving 458 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sandra Ictech United States	9	274	184	180	102	70	12	469
D D Bigner United States	11	226 0.8×	283 1.5×	115 0.6×	157 1.5×	85 1.2×	14	518
Swetlana Rot Germany	13	58 0.2×	273 1.5×	83 0.5×	109 1.1×	218 3.1×	17	431
Cory Mavis United States	16	159 0.6×	441 2.4×	29 0.2×	285 2.8×	77 1.1×	74	754
Craig Harlos Canada	8	99 0.4×	196 1.1×	81 0.5×	99 1.0×	115 1.6×	14	381
Christine Flefleh United States	9	104 0.4×	111 0.6×	64 0.4×	159 1.6×	30 0.4×	13	409
Swaroop Vakkalanka United States	11	266 1.0×	210 1.1×	56 0.3×	132 1.3×	21 0.3×	46	551
Atsushi Yawata Japan	10	22 0.1×	353 1.9×	50 0.3×	131 1.3×	85 1.2×	22	572
María J. García‐Barchino Spain	9	86 0.3×	237 1.3×	48 0.3×	290 2.8×	49 0.7×	10	508
Matteo Capaia Italy	12	103 0.4×	112 0.6×	77 0.4×	114 1.1×	60 0.9×	14	384

Countries citing papers authored by Sandra Ictech

Since Specialization

Citations

This map shows the geographic impact of Sandra Ictech's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Ictech with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Ictech more than expected).

Fields of papers citing papers by Sandra Ictech

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Ictech. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Ictech. The network helps show where Sandra Ictech may publish in the future.

Co-authorship network of co-authors of Sandra Ictech

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Ictech. A scholar is included among the top collaborators of Sandra Ictech based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Ictech. Sandra Ictech is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Penas‐Prado, Marta, Katayoun Rezvani, Shiao‐Pei Weathers, et al.. (2018). A phase I/II clinical trial of autologous CMV-specific cytotoxic T cells (CMV-TC) for glioblastoma: Dose escalation results.. Journal of Clinical Oncology. 36(15_suppl). 2035–2035. 1 indexed citations

2.

Penas‐Prado, Marta, Shiao‐Pei Weathers, Shouhao Zhou, et al.. (2018). ATIM-10. A PHASE I/II CLINICAL TRIAL OF AUTOLOGOUS CMV-SPECIFIC CYTOTOXIC T CELLS (CMV-TC) FOR GLIOBLASTOMA: DOSE ESCALATION AND CORRELATIVE RESULTS. Neuro-Oncology. 20(suppl_6). vi2–vi3. 3 indexed citations

3.

Levin, Victor A., Sandra Ictech, & Kenneth R. Hess. (2018). Clinical importance of eflornithine (α-difluoromethylornithine) for the treatment of malignant gliomas. CNS Oncology. 7(2). CNS16–CNS16. 31 indexed citations

4.

Giglio, Pierre, Kenneth R. Hess, Mark R. Gilbert, et al.. (2011). Phase 2 trial of irinotecan and thalidomide in adults with recurrent anaplastic glioma. Cancer. 118(14). 3599–3606. 12 indexed citations

5.

Groot, John de, Mark R. Gilbert, Ken Aldape, et al.. (2008). Phase II study of carboplatin and erlotinib (Tarceva, OSI-774) in patients with recurrent glioblastoma. Journal of Neuro-Oncology. 90(1). 89–97. 89 indexed citations

6.

Groves, Morris D., Michael Glantz, Marc C. Chamberlain, et al.. (2008). A multicenter phase II trial of intrathecal topotecan in patients with meningeal malignancies. Neuro-Oncology. 10(2). 208–215. 97 indexed citations

7.

Puduvalli, Vinay K., Pierre Giglio, Morris D. Groves, et al.. (2008). Phase II trial of irinotecan and thalidomide in adults with recurrent glioblastoma multiforme. Neuro-Oncology. 10(2). 216–222. 50 indexed citations

8.

Levin, Victor A., Sandra Ictech, & Kenneth R. Hess. (2007). Impact of phase II trials with progression-free survival as end-points on survival-based phase III studies in patients with anaplastic gliomas. BMC Cancer. 7(1). 106–106. 14 indexed citations

9.

Levin, Victor A., Kenneth R. Hess, Ali Choucair, et al.. (2003). Phase III randomized study of postradiotherapy chemotherapy with combination alpha-difluoromethylornithine-PCV versus PCV for anaplastic gliomas.. PubMed. 9(3). 981–90. 93 indexed citations

10.

Kyritsis, Athanassios P., W.K. Alfred Yung, Kurt A. Jaeckle, et al.. (1996). Combination of 6-Thioguanine, Procarbazine, Lomustine, and Hydroxyurea for Patients with Recurrent Malignant Gliomas. Neurosurgery. 39(5). 921–926. 3 indexed citations

11.

Kyritsis, Athanassios P., W.K. Alfred Yung, Kurt A. Jaeckle, et al.. (1996). Combination of 6-Thioguanine, Procarbazine, Lomustine, and Hydroxyurea for Patients with Recurrent Malignant Gliomas. Neurosurgery. 39(5). 921–926. 24 indexed citations

12.

Levin, Victor A., Michael D. Prados, W.K. Alfred Yung, et al.. (1992). Treatment of Recurrent Gliomas With Eflornithine. JNCI Journal of the National Cancer Institute. 84(18). 1432–1437. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact